Search Results
EBCC 8: Triple negative advanced breast cancer treatment with PARP inhibitors
ASCO 2009: PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer
ChemoSymposium 2011: PARP treatment for BRCA mutated and triple negative breast cancer
Case 3: Atezolizumab/Nab-Paclitaxel for Triple Negative Breast Cancer
Future Directions for Treatment of TNBC
Litton: The Promise of PARP Inhibitors
Dr. Arun on Immunogenicity in Triple-Negative Breast Cancer
Checkpoint inhibitors for triple-negative breast cancer
Case 3: Metastatic Triple-Negative Breast Cancer
SABCS: PARP Inhibitor Data Called 'Spectacular'
Treatments Under Investigation for Metastatic TNBC
Refining the role of PARP inhibitors in targeted anticancer therapy
